According to Jo Viney – Seismic’s founder, president, and chief executive, who was formerly head of R&D at Pandion, which was acquired by MSD/Merck & Co in 2021 – said that the new funding ...

guided by the best minds in immunology to discover novel biologics,” said Jo Viney, PhD, Chief Executive Officer of Seismic Therapeutic. “The strength of our approach is reinforced by our two ...